St. Jude launching Angstrom II and Contour II ICDs by March 1.
This article was originally published in The Gray Sheet
Executive Summary
ST. JUDE MEDICAL's ANGSTROM II, CONTOUR II ICD MARKET LAUNCH is anticipated by March 1, the firm reports Feb. 9. The products were approved by FDA Feb. 2 via premarket approval application supplements. The Angstrom II, with a volume of 44 cc, is the smallest implantable cardioverter defibrillator on the market, while the 57 cc Contour II is the most powerful, with up to 42 joules of maximum stored energy.